News about Cancer

The UB, Hospital Clínic and AstraZeneca create a knowledge transfer chair on lung cancer

The University of Barcelona, Hospital Clínic and the pharmaceutical company AstraZeneca created the UB-Hospital Clínic Chair on Lung Cancer AstraZene1

Clínic Barcelona

Research November 4 2020

Researchers develop an epigenetic clock that predicts the future clinical behavior of cancer patients

Spanish investigators from the IDIBAPS-Hospital Clínic of Barcelona have led an international effort to develop an epigenetic clock that is able to t1

Clínic Barcelona

Institutional May 26 2020

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1

Clínic Barcelona

Health Topics December 13 2019

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1

Clínic Barcelona

Research April 17 2019

A protein involved in cancer protects against muscle diseases

Researchers from the IDIBAPS Research Institute have found that the protein known as ZEB1 have beneficial or deleterious effects depending on its lev1

5 5

page1
page2
page3
page4
page5 , current page.

News about Cancer

The UB, Hospital Clínic and AstraZeneca create a knowledge transfer chair on lung cancer

Researchers develop an epigenetic clock that predicts the future clinical behavior of cancer patients

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

A protein involved in cancer protects against muscle diseases

navigation between pages below

Subscribe to the Newsletter of Clínic